Fastin Extended Release Proprietary Blend
Also known as: Fastin ER, Fastin Extended Release Proprietary Blend, Fastin Extended Release
Overview
Fastin Extended Release is a proprietary blend dietary supplement marketed for weight loss. Its exact composition is not publicly disclosed, but historically, Fastin products have contained stimulants. It is designed to suppress appetite and increase metabolism through an extended-release formulation. Due to its proprietary nature, there is limited peer-reviewed research specifically on Fastin Extended Release. Most available evidence relates to its known or suspected active ingredients, particularly stimulants like phentermine. The supplement is used primarily for weight loss and appetite control, aiming to provide sustained effects over time. However, the lack of transparency regarding its ingredients and the absence of direct clinical trials raise concerns about its efficacy and safety. Caution is advised due to the potential cardiovascular risks associated with stimulant-based weight loss supplements.
Benefits
The intended benefits of Fastin Extended Release are weight loss and appetite suppression. However, there are no direct, high-quality randomized controlled trials (RCTs) available to quantify these effects. Potential secondary benefits may include improvements in metabolic parameters associated with weight loss, but these are not specifically documented for this supplement. The extended-release formulation aims for sustained effects over several hours, but clinical data on the duration and magnitude of these benefits are lacking. The absence of direct studies makes it difficult to establish effect sizes or clinical significance. Intermittent fasting and caloric restriction have more robust evidence for weight loss benefits.
How it works
Fastin Extended Release likely works by stimulating the central nervous system, leading to appetite suppression and increased energy expenditure, similar to phentermine and other sympathomimetic amines. It is believed to act on neurotransmitters such as norepinephrine and dopamine to reduce hunger and increase metabolic rate. The primary molecular targets are likely adrenergic receptors in the central nervous system. The extended-release formulation is designed to maintain plasma levels over time, with pharmacokinetic data on similar compounds showing delayed Tmax and sustained plasma concentrations. However, there is no direct pharmacokinetic data available specifically for Fastin Extended Release.
Side effects
Safety concerns exist with stimulant-based weight loss supplements like Fastin Extended Release, primarily due to potential cardiovascular risks. Common side effects (occurring in >5% of users) may include increased heart rate, elevated blood pressure, insomnia, and nervousness. Uncommon side effects (1-5%) can include headache, dry mouth, and gastrointestinal discomfort. Rare but potentially serious side effects (<1%) include cardiovascular events and dependency. Fastin Extended Release may interact with other stimulants, monoamine oxidase inhibitors (MAOIs), and antihypertensives. It is contraindicated in individuals with cardiovascular disease, hypertension, hyperthyroidism, and during pregnancy. It is not recommended for pregnant or breastfeeding women, children, or individuals with cardiovascular conditions.
Dosage
Due to the lack of direct clinical trials, the minimum effective dose, optimal dosage ranges, and maximum safe dose of Fastin Extended Release are not established. Typically, extended-release stimulant supplements are dosed once or twice daily, but the exact dosing for Fastin ER is proprietary. Caution is advised due to the stimulant content. It is usually taken in the morning to avoid insomnia. The extended-release tablets are designed for gradual absorption. Food may alter absorption, but extended-release formulations are generally designed to mitigate peak plasma spikes. There are no documented required cofactors.
FAQs
Is Fastin Extended Release safe?
Safety is uncertain without independent studies. Stimulant-based supplements carry cardiovascular risks, so caution is advised. Consult with a healthcare provider before use.
How quickly does it work?
Extended-release formulations aim for gradual onset over several hours, but individual responses may vary. There is limited data on the specific onset and duration of effects for Fastin ER.
Can it be taken with other medications?
Potential interactions exist with other stimulants, MAOIs, and antihypertensives. Consult a healthcare provider to assess potential drug interactions before use.
Is it effective for long-term weight loss?
No direct evidence supports long-term efficacy or safety. Sustainable lifestyle changes, such as diet and exercise, are generally recommended for long-term weight management.
Are there natural alternatives?
Intermittent fasting and caloric restriction have more robust evidence for weight loss benefits. Consult with a healthcare provider or registered dietitian for personalized recommendations.
Research Sources
- https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/ – This fact sheet from the NIH Office of Dietary Supplements notes that many weight loss supplements lack rigorous evidence for efficacy and safety. It emphasizes the need for caution when considering these supplements and highlights the importance of consulting with healthcare professionals.
- https://www.mdpi.com/2072-6643/16/20/3533 – This systematic review examines the effects of intermittent fasting on weight loss. The review suggests that intermittent fasting can be an effective strategy for weight management, but further research is needed to determine its long-term effects and optimal protocols.
- https://www.mdpi.com/2072-6643/15/11/2604 – This systematic review investigates the impact of intermittent fasting on appetite regulation. The review indicates that intermittent fasting may influence appetite-related hormones and subjective feelings of hunger, potentially contributing to weight loss.
- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022580orig1s000medr.pdf – This FDA New Drug Application (NDA) review for Qsymia (phentermine/topiramate extended release) provides detailed information on the efficacy and safety of this prescription weight loss medication. The review highlights significant weight loss achieved with Qsymia in clinical trials, but also emphasizes the importance of careful safety monitoring due to potential side effects.
- https://journals.sagepub.com/doi/full/10.1177/0976500X221111669 – This study investigates the effectiveness of a weight loss program that includes dietary changes and exercise. The results suggest that a comprehensive approach to weight loss, combining lifestyle modifications with support and guidance, can lead to significant improvements in weight and metabolic health.
Recommended Articles
Top Fertility Supplements for Women in 2025
By 2025, new FDA-approved fertility supplements, emphasizing organic ingredients, have shown significant effectiveness in aiding conception for women in their 30s.
Barcode-Scanner Apps & Supplements: A Reality Check
Barcode-scanner supplement apps vary in accuracy, especially with proprietary blends, but advancements are improving their reliability.
Legal Pre-Workout Supplements for Athletes
Legal pre-workout supplements like those with caffeine, beta-alanine, and creatine can safely enhance athletic performance without failing doping tests.
Top Testosterone Boosters for Cyclists: A Buyer's Guide
For cyclists, choosing testosterone boosters involves finding scientifically-backed, third-party tested products, with top picks including brands like TestoGen and Prime Male.